In a triple-transgenic mouse model of Alzheimer's disease, repeated challenges with lipopolysaccharide were shown to exacerbate central nervous system inflammation and to cause increased tau phosphorylation [28]. The gene discussed is MAPT; the disease is Alzheimer disease.